Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A lab-on-a-chip compatible bioaffinity assay method for human alpha-fetoprotein.

Janne O Koskinen1, Niko J Meltola, Erkki Soini

  • 1Laboratory of Biophysics, Institute of Biomedicine, University of Turku, Finland.

Lab on a Chip
|November 16, 2005
PubMed
Summary

A novel lab-on-a-chip assay platform integrates dry-chemistry reagents with ArcDia TPX technology. This innovation enables sensitive bioaffinity detection in miniature volumes, addressing a key need in microchip development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary hypertension in Finland 2008-2020: A descriptive real-world cohort study (FINPAH).

JHLT open·2025
Same author

Ustekinumab for ulcerative colitis: a nationwide real-life observational cohort study.

European journal of gastroenterology & hepatology·2025
Same author

Treatment pathways in Finnish patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH).

Pulmonary circulation·2025
Same author

Patient-Reported Outcomes of Visual Disturbances with a Trifocal Intraocular Lens: A Meta-Analysis.

Ophthalmology and therapy·2024
Same author

Cost-Effectiveness of Empagliflozin in Combination with Standard Care versus Standard Care Only in the Treatment of Heart Failure Patients in Finland.

ClinicoEconomics and outcomes research : CEOR·2023
Same author

Advantages in Management and Remote Monitoring of Intravenous Therapy: Exploratory Survey and Economic Evaluation of Gravity-Based Infusions in Finland.

Advances in therapy·2022

Area of Science:

  • Biotechnology
  • Analytical Chemistry
  • Microfluidics

Background:

  • Microchip-based assays often lack compatible, cost-effective, and sensitive detection platforms.
  • Existing methods may not be suitable for miniature reaction volumes common in lab-on-a-chip systems.

Purpose of the Study:

  • To introduce and evaluate a new lab-on-a-chip compatible binding assay platform.
  • To combine dry-chemistry bioaffinity reagents with the ArcDia TPX detection technique.
  • To assess the platform's performance for sensitive bioaffinity detection in micro-volumes.

Main Methods:

  • Utilized polymer microspheres as reaction carriers with fluorescently labeled antibody conjugates.
  • Employed two-photon excitation fluorescence for detecting emission from individual microspheres.

Related Experiment Videos

  • Validated the platform using an immunometric assay for human alpha-fetoprotein (hAFP) in a 384-plate format.

    • Main Results:

    • The ArcDia TPX technique successfully integrated with dry-chemistry reagents without compromising assay performance.
    • Signal response was independent of reaction volume, confirming suitability for miniature volumes.
    • Performance metrics were comparable to traditional wet-chemistry assay methods.

    Conclusions:

    • The developed assay platform offers a microchip-compatible solution for sensitive bioaffinity detection.
    • This technology addresses the shortage of suitable detection platforms in the microchip field.
    • The integration of dry-chemistry and ArcDia TPX enables cost-effective and sensitive microchip assay designs.